Loading stock data…
Evolent Health, Inc (EVH)
$5.77+0.26 (+4.72%)
After Hours$5.56-0.21 (-3.64%)· Last close Jun 29
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Evolent Health, Inc. in the Healthcare sector is trading at $5.77 with a market capitalization of $425M. Wall Street consensus targets $5.88 (13 analysts), implying a +2.0% move over the next 12 months. The stock is currently 52% below its 52-week high of $12.06, remaining 27.7% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $496.25M↑ | $468.72M↓ | $479.53M↑ | $444.33M↓ | $483.65M |
| Gross Profit | $83.77M↓ | $97.25M↓ | $99.77M↓ | $100.39M↓ | $102.47M |
| Operating Income | -$10.60M↑ | -$20.44M↓ | -$1.43M↓ | $2.04M↑ | $4,000 |
| Net Income | -$26.63M↑ | -$429.13M↓ | -$20.86M↓ | -$19.90M↑ | -$64.62M |
Peer Comparison
JNJUNHPFE
Fundamentals
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administratio...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$425.18M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.83
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-125.26%
Volume
Today's trading volume
2.95M
Recent News
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?
Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Q1 Earnings Outperformers: Evolent Health (NYSE:EVH) And The Rest Of The Healthcare Technology for Providers Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare technology for providers stocks fared in Q1, starting with Evolent Health (NYSE:EVH).
Veeva's Falcon and Vault AI: When Could AI Become a Revenue Driver?
VEEV's Falcon and Vault AI deepen workflow automation across life sciences, while management expects AI revenues to remain immaterial in fiscal 2027.
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position?
Privia Health Group delivers technology-driven solutions to optimize physician practices and support value-based care nationwide.
3 Healthcare Stocks We Approach with Caution
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently - over the past six months, the collective 4.1% gain for healthcare stocks has fallen short of the S&P 500’s 10.3% rise.